You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百克生物(688276.SH)及長春高新終止與思安信關於新型冠狀病毒疫苗(PIV-5載體)的許可合作

格隆匯9月27日丨百克生物(688276.SH)公佈,公司及母公司——長春高新技術產業(集團)股份有限公司(“長春高新”)將終止與廣州思安信生物技術有限公司(“思安信”)關於新型冠狀病毒疫苗(PIV-5載體)的許可合作關聯交易。上述終止關聯交易事項已於2021927日經百克生物第四屆董事會第十八次會議審議通過,關聯董事已迴避表決。獨立董事發表同意終止此次交易的獨立意見。此次交易的終止尚需提交公司股東大會進行審議。

截至公吿日止,長春高新、百克生物公司未開展該交易事項涉及的相關研究工作,新型冠狀病毒疫苗(PIV-5 載體)研發進行實際投入百克生對該項目進行調研、評估支出155.35萬元,終止此次交易不會對公司經營業績產生不利影響關於該事項的後續進展,公司將嚴格按照監管部門有關要求,及時履行信息披露義務,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account